Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

April 20, 2017

Conditions
Atrial Fibrillation
Trial Locations (1)

48073

Beaumont Health System, Royal Oak

Sponsors
All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

London Health Sciences Centre

OTHER

lead

William Beaumont Hospitals

OTHER

NCT01607359 - Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation | Biotech Hunter | Biotech Hunter